1. Home
  2. CAPR vs GCBC Comparison

CAPR vs GCBC Comparison

Compare CAPR & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$6.71

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

SELL

Current Price

$34.32

Market Cap

569.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
CAPR
GCBC
Founded
2005
1889
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
584.9M
569.0M
IPO Year
2011
1998

Fundamental Metrics

Financial Performance
Metric
CAPR
GCBC
Price
$6.71
$34.32
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $27.00
N/A
AVG Volume (30 Days)
★ 2.5M
30.8K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
★ 1.28%
EPS Growth
N/A
★ 31.69
EPS
N/A
★ 2.41
Revenue
N/A
★ $4,117,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.52
N/A
P/E Ratio
★ N/A
$14.21
Revenue Growth
N/A
★ 11.06
52 Week Low
$2.96
$21.38
52 Week High
$40.37
$36.33

Technical Indicators

Market Signals
Indicator
CAPR
GCBC
Relative Strength Index (RSI) 39.26 49.25
Support Level $6.01 $34.05
Resistance Level $10.12 $35.84
Average True Range (ATR) 0.53 0.63
MACD -0.15 0.01
Stochastic Oscillator 9.03 76.19

Price Performance

Historical Comparison
CAPR
GCBC

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: